Market Research Future
Molecular Diagnostics Market is expected to expand 9.6% CAGR during the forecast period 2019 to 2023
Molecular Diagnostics Market – Scenario The reagents used in molecular diagnostics play important role in primary diagnosis and treatment of diseases at molecular level. The instruments like PCR and next generation sequencing has shown reliable test results and are rapid in nature which resulting increasing demand in central laboratories diagnostics institutes. Moreover, molecular testing tools are providing better alternatives in detecting in infectious viral, bacterial and other pathogens. All these factors are responsible for growth of the market positively. Furthermore, increasing prevalence of infectious diseases like influenza and human papillomavirus and others also boost the growth of the market. On the other hand, higher price of molecular diagnostic kits may hinder the growth of the market.
Global molecular diagnostics market is expected to grow at a CAGR of 9.6% during forecasted period 2017-2023.
Request Free Sample https://www.marketresearchfuture.com/sample_request/1171
Copy
at
Key Players The top key players in global molecular diagnostics market F. Hoffmann-La Roche Ltd. (U.S.), QIAGEN N.V. (the Netherlands), Hologic, Inc. (U.S.), Grifols (Spain), Abbott (U.S.), Siemens Healthcare GmbH(Germany), Bio-Rad Laboratories, Inc.(US), BD (U.S.), Beckman Coulter Inc. (U.S.), bioMĂŠrieux SA (France), and Cepheid (U.S.).
Bio-Rad Laboratories, Inc. is the US headquartered company which develops, manufactures and market a wide range of products for molecular diagnostic and research. In Feb 2016, the company got approval for QX200, Droplet which are the first digital PCR systems. Bio-rad has a wide range of molecular diagnostic tools.